Bhang Inc. (BHNGF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.94: the stock has moved about 94% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBhang Inc. (BHNGF) trades at $0.0001. Bhang Inc. is a cannabis consumer packaged goods company based in Canada, offering a range of cannabis and hemp-derived CBD products. The company distributes its products through partners and licensees worldwide. Sector: Healthcare.
Price as of · Last analyzed: Mar 15, 2026Analyst Coverage for BHNGF: BHNGF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Bhang Inc. (BHNGF) Healthcare & Pipeline Overview
Bhang Inc. is a cannabis consumer packaged goods company focused on chocolates, pre-rolls, vapes, and gummies. Operating in the United States and distributing internationally through partners, Bhang faces competition in the evolving cannabis market while navigating regulatory complexities and striving for profitability with a negative profit margin.
What Is the Investment Thesis for BHNGF?
Bhang Inc. operates in the high-growth cannabis consumer packaged goods sector but faces significant challenges. With a negative P/E ratio and a profit margin of -260.4%, the company's path to profitability is uncertain. The high beta of 1.94 indicates significant volatility compared to the market. Growth catalysts include expanding its product line and distribution network. However, regulatory hurdles and intense competition pose substantial risks. Investors should carefully consider the company's financial performance and market position before investing, given the speculative nature of the cannabis industry and Bhang's current financial metrics.
Based on FMP financials and quantitative analysis
BHNGF Key Highlights
Market Cap of $0.00B indicates a small-cap company with limited financial resources.
- Negative P/E Ratio of -0.00 reflects the company's current lack of profitability.
- Profit Margin of -260.4% highlights significant challenges in achieving profitability.
- Gross Margin of 66.5% suggests potential for profitability if operating expenses are managed effectively.
- Beta of 1.94 indicates high volatility compared to the overall market.
Who Are BHNGF's Competitors?
BHNGF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $11.4M | — |
| COSM COSM | $0.35 | -9.03% | $20.7M | — |
| AYTU Aytu BioPharma, Inc. | $2.04 | -1.45% | $21.9M | — |
| QNTM Quantum BioPharma Ltd. | $3.27 | -4.94% | $22.0M | — |
| TXMD TherapeuticsMD, Inc. | $2.01 | -1.95% | $24.0M | — |
| CPHI CPHI | $0.65 | -0.61% | $27.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BHNGF's Key Strengths?
Established brand in cannabis edibles.
- Diverse product portfolio.
- Global distribution network.
- Strong gross margin.
What Are BHNGF's Weaknesses?
Negative profit margin.
- Limited market capitalization.
- High beta indicating volatility.
- Dependence on regulatory approvals.
What Are the Key Risks for BHNGF?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis market could erode market share.
- Evolving regulatory landscape could create compliance challenges.
- Fluctuations in cannabis prices could impact profitability.
- Product recalls could damage brand reputation.
- Limited financial resources may constrain growth initiatives.
What Are BHNGF's Competitive Advantages?
- Brand Recognition: Established brand presence in the cannabis-infused edibles market.
- Distribution Network: Partnerships with distributors and licensees provide global reach.
- Product Innovation: Continuous development of new and innovative cannabis products.
- Proprietary Formulations: Unique and differentiated product formulations.
What Does BHNGF Do?
Bhang Inc., based in Toronto, Canada, operates as a cannabis consumer packaged goods brand company in the United States. The company's origins lie in crafting premium cannabis-infused chocolates and has since evolved to offer a diverse portfolio of products. These include cannabis, hemp-derived cannabidiol (CBD), and terpene products such as chocolates, pre-rolls, vapes, gums, beverages, and gummies. Bhang's product line features a variety of chocolate flavors, including milk chocolate, dark chocolate, and white chocolate variations, as well as infused joints. The company distributes its cannabis-infused products through a network of partners and licensees, extending its reach worldwide. Bhang aims to establish a strong brand presence in the competitive cannabis market by focusing on product innovation and strategic partnerships. The company's success hinges on navigating the complex regulatory landscape and achieving profitability in a rapidly evolving industry.
What Products and Services Does BHNGF Offer?
- Develops and markets cannabis-infused chocolates and other edibles.
- Offers a range of cannabis and hemp-derived CBD products.
- Distributes products through partners and licensees worldwide.
- Creates various chocolate flavors, including milk chocolate, dark chocolate, and white chocolate.
- Produces infused joints and other cannabis-related products.
- Operates in the United States and Canada.
How Does BHNGF Make Money?
- Develops and manufactures cannabis-infused products.
- Partners with distributors and licensees for global distribution.
- Generates revenue through sales of cannabis and CBD products.
- Focuses on brand building and marketing to drive sales.
What Industry Does BHNGF Operate In?
Bhang Inc. operates within the rapidly expanding cannabis consumer packaged goods market. This industry is characterized by evolving regulations, increasing consumer acceptance, and intense competition. Market trends include the growing demand for diverse cannabis products, such as edibles and vapes, and the expansion of legal cannabis markets across the United States and globally. Bhang competes with other cannabis brands and established consumer packaged goods companies entering the market. The company's success depends on its ability to differentiate its products, build brand loyalty, and navigate the complex regulatory landscape.
Who Are BHNGF's Key Customers?
- Adult consumers seeking cannabis-infused products.
- Retailers and dispensaries selling cannabis products.
- Partners and licensees distributing Bhang products.
- Consumers interested in hemp-derived CBD products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for Bhang Inc. stands at 400.1%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 1.22 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
Bhang Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO John Graham Simmonds Jr.. BHNGF has traded publicly since 2007.
Financial Health
Bhang Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
BHNGF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
BHNGF Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
BHNGF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BHNGF.
Price Targets
Wall Street price target analysis for BHNGF.
BHNGF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BHNGF; grades run from A+ (80-100) to F (below 30).
Leadership: John Graham Simmonds Jr.
CEO
John Graham Simmonds Jr. is the Chief Executive Officer of Bhang Inc. His background includes experience in the cannabis consumer packaged goods sector. He has been involved in various aspects of the cannabis industry, including product development, distribution, and marketing. His expertise lies in building brand awareness and driving revenue growth in the competitive cannabis market. He has a strong understanding of the regulatory landscape and consumer preferences.
Track Record: Under John Graham Simmonds Jr.'s leadership, Bhang Inc. has focused on expanding its product line and distribution network. Key achievements include establishing partnerships with distributors and licensees to extend the company's global reach. Strategic decisions have centered on product innovation and brand building to differentiate Bhang from competitors. The company has navigated the complex regulatory environment and adapted to evolving consumer trends.
BHNGF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bhang Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and transparency compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low trading volume and liquidity.
- Higher risk of price manipulation.
- Lack of regulatory oversight.
- Potential for delisting or suspension of trading.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Monitor trading volume and price volatility.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Established brand in the cannabis edibles market.
- Global distribution network through partners and licensees.
- Continuous development of new and innovative products.
- Presence in the cannabis consumer packaged goods sector.
- Active management team focused on growth and expansion.
Bhang Inc. Healthcare Stock: Key Questions Answered
What are the main risks for BHNGF?
Bhang Inc. faces several risks inherent in the cannabis industry, including intense competition, evolving regulations, and fluctuations in cannabis prices. Product recalls and damage to brand reputation are also potential risks.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.